Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Vesicle-associated membrane protein 1 (VAMP1) and 2 (VAMP2), also known as synaptobrevin 1 and 2, are essential v-SNARE proteins located on the membranes of synaptic vesicles [1, 2]. They play a critical role in the molecular machinery of exocytosis by pairing with t-SNAREs (SNAP-25 and Syntaxin-1) on the presynaptic plasma membrane to form the SNARE complex, which drives membrane fusion and neurotransmitter release [4, 8]. VAMP1 is predominantly expressed in the spinal cord and motor neurons, while VAMP2 is the major isoform in the brain and is involved in fast, calcium-triggered synaptic transmission [11, 19]. These proteins are the primary targets of several clostridial neurotoxins, most notably Botulinum toxin type B and Tetanus toxin, which cleave VAMP at specific sites to block neurotransmission [13, 15]. Clinically, drugs like RimabotulinumtoxinB exploit this mechanism to treat conditions characterized by muscle overactivity, such as cervical dystonia [10, 15]. Beyond their role as toxin targets, VAMP proteins are being investigated as biomarkers for synaptic degeneration in neurodegenerative diseases like Alzheimer's [5, 20].
Zinc-dependent proteolytic cleavage of VAMP proteins by the toxin's light chain, which prevents the assembly of the functional SNARE complex and subsequently blocks the exocytosis of neurotransmitters [13, 15].
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vesicle-associated membrane protein 1 and 2 (VAMP1/2).